Global Biopharmaceutical Leader UCB Selects IDBS’ BioBook for DMPK and Pharmacology

Guildford, UK, February 11, 2008 – IDBS today announced that the global biopharmaceutical company UCB has licensed BioBook to be deployed across multiple European sites for DMPK (Drug Metabolism and Pharmacokinetics) and pharmacology. UCB focuses on developing breakthrough treatments for…